TipRanks
Advertisement
Advertisement

VTGN Stock Latest News

VistaGen Therapeutics Updates Executive Severance and Control Plan
Company AnnouncementsVistaGen Therapeutics Updates Executive Severance and Control Plan
2d ago
8K
VTGN
VistaGen Updates Strategy for Pherine-Based CNS Therapies
PremiumCompany Announcements
VistaGen Updates Strategy for Pherine-Based CNS Therapies
16d ago
8K
VTGN
SRX Global says adds investment in Onconetix
PremiumThe Fly
SRX Global says adds investment in Onconetix
17d ago
GRML
ONCO
VistaGen highlights Phase 3 data in severe social anxiety
PremiumCompany Announcements
VistaGen highlights Phase 3 data in severe social anxiety
17d ago
8K
VTGN
Vistagen presents data on fasedienol nasal spray at Psych Congress 2026
PremiumThe Fly
Vistagen presents data on fasedienol nasal spray at Psych Congress 2026
17d ago
VTGN
VistaGen Reports Positive Long-Term Fasedienol Anxiety Data
PremiumCompany AnnouncementsVistaGen Reports Positive Long-Term Fasedienol Anxiety Data
19d ago
8K
VTGN
Vistagen announces preliminary data from OLE of Palisade-4 Phase 3 study
Premium
The Fly
Vistagen announces preliminary data from OLE of Palisade-4 Phase 3 study
19d ago
VTGN
VistaGen Stockholders Reaffirm Board, Governance and Oversight
Premium
Company Announcements
VistaGen Stockholders Reaffirm Board, Governance and Oversight
30d ago
8K
VTGN
Vistagen Therapeutics Lawsuit: Company Seeks Dismissal of Investor Securities Claims
PremiumClass Action
Vistagen Therapeutics Lawsuit: Company Seeks Dismissal of Investor Securities Claims
1M ago
VTGN
VistaGen reports Phase 2 fasedienol trial topline results
PremiumCompany Announcements
VistaGen reports Phase 2 fasedienol trial topline results
2M ago
8K
VTGN
Vistagen announces topline results from fasedienol repeat dose study
PremiumThe Fly
Vistagen announces topline results from fasedienol repeat dose study
2M ago
VTGN
VistaGen Granted Nasdaq Extension to Regain Bid Compliance
PremiumCompany Announcements
VistaGen Granted Nasdaq Extension to Regain Bid Compliance
2M ago
8K
VTGN
SRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics
PremiumTipRanks NewswireSRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics
2M ago
SRXH
VTGN
SRX Global acquires stake in Vistagen
Premium
The Fly
SRX Global acquires stake in Vistagen
2M ago
SRXH
VTGN
Vistagen Therapeutics Inc. (VTGN) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Vistagen Therapeutics Inc. (VTGN) Q1 Earnings Cheat Sheet
2M ago
VTGN
VistaGen Therapeutics Appoints Douglas Williamson to Board
PremiumCompany Announcements
VistaGen Therapeutics Appoints Douglas Williamson to Board
2M ago
8K
VTGN
VistaGen pivots fasedienol toward long-term anxiety treatment
PremiumCompany Announcements
VistaGen pivots fasedienol toward long-term anxiety treatment
3M ago
8K
VTGN
Vistagen announces fasedienol did not achieve primary endpoint
PremiumThe Fly
Vistagen announces fasedienol did not achieve primary endpoint
3M ago
VTGN
Vistagen Therapeutics’ 2026 Workforce Cuts Raise Execution Risks and Threaten Long-Term Growth
PremiumCompany Announcements
Vistagen Therapeutics’ 2026 Workforce Cuts Raise Execution Risks and Threaten Long-Term Growth
4M ago
VTGN
VistaGen Reaches Key Safety Milestone for Fasedienol Program
PremiumCompany AnnouncementsVistaGen Reaches Key Safety Milestone for Fasedienol Program
4M ago
8K
VTGN
Vistagen announces fasedienol achieves minimum patient exposures
Premium
The Fly
Vistagen announces fasedienol achieves minimum patient exposures
4M ago
VTGN
VistaGen Appoints New Chief Medical Officer to Advance Pipeline
Premium
Company Announcements
VistaGen Appoints New Chief Medical Officer to Advance Pipeline
5M ago
8K
VTGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >